omeprazole has been researched along with Gastritis, Atrophic in 53 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Gastritis, Atrophic: GASTRITIS with atrophy of the GASTRIC MUCOSA, the GASTRIC PARIETAL CELLS, and the mucosal glands leading to ACHLORHYDRIA. Atrophic gastritis usually progresses from chronic gastritis.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This prospective randomised study aimed to investigate whether H pylori eradication can influence gastritis and its sequelae during long term omeprazole therapy for gastro-oesophageal reflux disease (GORD)." | 9.11 | Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. ( Dent, J; Festen, HP; Goldfain, D; Havu, N; Klinkenberg-Knol, EC; Kolkman, JJ; Kuipers, EJ; Lamm, M; Nelis, GF; Snel, P; Walan, A; Zeitoun, P, 2004) |
| " This prospective randomised study aimed to investigate whether H pylori eradication can influence gastritis and its sequelae during long term omeprazole therapy for gastro-oesophageal reflux disease (GORD)." | 5.11 | Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. ( Dent, J; Festen, HP; Goldfain, D; Havu, N; Klinkenberg-Knol, EC; Kolkman, JJ; Kuipers, EJ; Lamm, M; Nelis, GF; Snel, P; Walan, A; Zeitoun, P, 2004) |
| " The most common adverse events of headache, diarrhea, and nausea have been reported in fewer than 5% of patients treated with lansoprazole or omeprazole." | 4.80 | Safety profile of the proton-pump inhibitors. ( Reilly, JP, 1999) |
| "Omeprazole maintenance therapy for gastro-oesophageal reflux disease (GERD) has been associated with an increased incidence of atrophic gastritis in H." | 3.70 | Atrophic gastritis during long-term omeprazole therapy affects serum vitamin B12 levels. ( Bloemena, EC; Festen, HP; Klinkenberg-Knol, EC; Kuipers, EJ; Meuwissen, SG; Nelis, GF; Sandell, M; Schenk, BE; Snel, P, 1999) |
| " pylori testing in patients on profound acid suppressive therapy should be performed on combined corpus and antral specimens, and 2) that omeprazole therapy leads to a strong increase in corpus gastritis, which may explain the observed development of corpus atrophy in a substantial number of patients after several years of continuous acid suppressive treatment." | 3.69 | Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. ( Bloemena, E; Hazenberg, HJ; Klinkenberg-Knol, EC; Kuipers, EJ; Lindeman, J; Meuwissen, SG; Peña, AS; Uyterlinde, AM, 1995) |
| " Serum gastrin levels, non-antral gastric endocrine (argyrophil) cell growth, and the severity and type of concomitant gastritis were monitored in 66 unoperated and 8 antrectomized patients with poorly responsive peptic ulcer or reflux oesophagitis during up to 5 years' treatment with high-dose omeprazole, 40 mg daily." | 3.68 | Inter-relationship between serum gastrin levels, gastric mucosal histology and gastric endocrine cell growth. ( Creutzfeldt, W; Lamberts, R, 1992) |
| "pylori at 6 wk were infected at 1 yr (recurrence rates 10." | 2.70 | Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure. ( Figueroa, LS; Guarner, J; Halperin, D; Herrera-Goepfert, R; Ley, C; Mohar, A; Parsonnet, J, 2002) |
| "To investigate the effects of hypochlorhydria and acidic drink ingestion on protein-bound vitamin B12 absorption in elderly subjects." | 2.67 | Effect of hypochlorhydria due to omeprazole treatment or atrophic gastritis on protein-bound vitamin B12 absorption. ( Dallal, GE; Golner, BB; Kemp, JA; Pedrosa, MC; Russell, RM; Saltzman, JR, 1994) |
| " Herewith, we present an overview of these intragastric changes, particularly during long-term administration of acid-suppresive medication and concurrent infection with Helicobacter pylori." | 2.41 | Changes in gastric mucosa and luminal environment during acid-suppressive therapy: a review in depth. ( de Bruïne, A; Hameeteman, W; Jonkers, D; Sanduleanu, S; Stockbrügger, RW, 2001) |
| " However, the consequences of very long-term use of proton pump inhibitors remain unknown." | 2.41 | Problems associated with the clinical use of proton pump inhibitors. ( Gillen, D; McColl, KE, 2001) |
| "pylori and GERD and its potential implications for the management of GERD." | 2.40 | Review article: Helicobacter pylori and gastro-oesophageal reflux disease-clinical implications and management. ( O'Connor, HJ, 1999) |
| " Whether used alone or combined with omeprazole (OME), it shows a significant effect." | 1.91 | Weikangling capsules combined with omeprazole ameliorates ethanol-induced chronic gastritis by regulating gut microbiota and EGF-EGFR-ERK pathway. ( Li, X; Liu, F; Nong, X; Qu, W, 2023) |
| "Gastritis is a common inflammation of stomach with multiple pathogenesis." | 1.72 | Octreotide-based therapies effectively protect mice from acute and chronic gastritis. ( Cao, LJ; Cao, WL; Che, Y; Ding, CJ; Huang, H; Wang, Y; Wu, JW; Xu, WF; Zhang, Q, 2022) |
| "Omeprazole pretreatment ameliorated DMP-777-induced parietal cell loss as well as foveolar hyperplasia." | 1.33 | Omeprazole treatment ameliorates oxyntic atrophy induced by DMP-777. ( Car, BD; Goldenring, JR; Nomura, S; Ogawa, M, 2006) |
| "Chronic atrophic gastritis was found in 45 (10." | 1.28 | Gastric endocrine cells and gastritis in patients receiving long-term omeprazole treatment. ( Carlsson, R; Dalväg, A; Fiocca, R; Havu, N; Solcia, E, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 27 (50.94) | 18.2507 |
| 2000's | 20 (37.74) | 29.6817 |
| 2010's | 1 (1.89) | 24.3611 |
| 2020's | 5 (9.43) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, WF | 1 |
| Wang, Y | 1 |
| Huang, H | 1 |
| Wu, JW | 1 |
| Che, Y | 1 |
| Ding, CJ | 1 |
| Zhang, Q | 1 |
| Cao, WL | 1 |
| Cao, LJ | 1 |
| Liu, F | 1 |
| Nong, X | 1 |
| Qu, W | 1 |
| Li, X | 1 |
| Crafa, P | 1 |
| Franceschi, M | 1 |
| Rodriguez-Castro, KI | 1 |
| Franzoni, L | 1 |
| Russo, M | 1 |
| Brandimarte, G | 1 |
| Tursi, A | 1 |
| Rugge, M | 1 |
| Di Mario, F | 1 |
| Valencia, ME | 1 |
| Montejano, R | 1 |
| Moreno, V | 1 |
| Martín Carbonero, L | 1 |
| Bernardino, JI | 1 |
| Serrano, L | 1 |
| Kodama, M | 1 |
| Okimoto, T | 1 |
| Mizukami, K | 1 |
| Hirashita, Y | 1 |
| Wada, Y | 1 |
| Fukuda, M | 1 |
| Matsunari, O | 1 |
| Okamoto, K | 1 |
| Ogawa, R | 1 |
| Fukuda, K | 1 |
| Kudo, Y | 1 |
| Kawahara, Y | 1 |
| Murakami, K | 2 |
| Zhou, L | 1 |
| Lin, S | 1 |
| Ding, S | 1 |
| Huang, X | 1 |
| Jin, Z | 1 |
| Cui, R | 1 |
| Meng, L | 1 |
| Li, Y | 1 |
| Zhang, L | 1 |
| Guo, C | 1 |
| Xue, Y | 1 |
| Yan, X | 1 |
| Zhang, J | 1 |
| Sugiyama, T | 1 |
| Tsuchida, M | 1 |
| Yokota, K | 1 |
| Shimodan, M | 1 |
| Asaka, M | 2 |
| Mitsunaga, A | 1 |
| Matsumoto, R | 1 |
| Hoshino, Y | 1 |
| Nakamura, S | 1 |
| Murata, Y | 1 |
| Oi, I | 1 |
| Hayashi, N | 1 |
| Mohar, A | 1 |
| Ley, C | 1 |
| Guarner, J | 1 |
| Herrera-Goepfert, R | 1 |
| Figueroa, LS | 1 |
| Halperin, D | 1 |
| Parsonnet, J | 1 |
| Konturek, PC | 1 |
| Rembiasz, K | 1 |
| Konturek, SJ | 1 |
| Stachura, J | 1 |
| Bielanski, W | 1 |
| Galuschka, K | 1 |
| Karcz, D | 1 |
| Hahn, EG | 1 |
| Kamada, T | 1 |
| Haruma, K | 1 |
| Hata, J | 1 |
| Kusunoki, H | 1 |
| Sasaki, A | 1 |
| Ito, M | 1 |
| Tanaka, S | 1 |
| Yoshihara, M | 1 |
| Kuipers, EJ | 9 |
| Nelis, GF | 4 |
| Klinkenberg-Knol, EC | 9 |
| Snel, P | 4 |
| Goldfain, D | 1 |
| Kolkman, JJ | 1 |
| Festen, HP | 6 |
| Dent, J | 1 |
| Zeitoun, P | 2 |
| Havu, N | 3 |
| Lamm, M | 1 |
| Walan, A | 1 |
| Hershko, C | 1 |
| Hoffbrand, AV | 1 |
| Keret, D | 1 |
| Souroujon, M | 1 |
| Maschler, I | 1 |
| Monselise, Y | 1 |
| Lahad, A | 1 |
| Raghunath, AS | 1 |
| O'Morain, C | 1 |
| McLoughlin, RC | 1 |
| Ogawa, M | 1 |
| Nomura, S | 1 |
| Car, BD | 1 |
| Goldenring, JR | 1 |
| Uyterlinde, AM | 1 |
| Peña, AS | 1 |
| Hazenberg, HJ | 1 |
| Bloemena, E | 2 |
| Lindeman, J | 2 |
| Meuwissen, SG | 8 |
| Saltzman, JR | 1 |
| Kemp, JA | 1 |
| Golner, BB | 1 |
| Pedrosa, MC | 1 |
| Dallal, GE | 1 |
| Russell, RM | 1 |
| Burette, A | 1 |
| Glupczynski, Y | 1 |
| Wormsley, KG | 1 |
| Borody, TJ | 1 |
| Andrews, P | 1 |
| Jankiewicz, E | 1 |
| Ferch, N | 1 |
| Carroll, M | 1 |
| Lee, A | 1 |
| Lundell, L | 1 |
| Liedman, B | 1 |
| Lamers, CB | 1 |
| Jansen, JB | 1 |
| Dalenback, J | 1 |
| Camilo, E | 1 |
| Zimmerman, J | 1 |
| Mason, JB | 1 |
| Golner, B | 1 |
| Russell, R | 1 |
| Selhub, J | 1 |
| Rosenberg, IH | 1 |
| Repucci, AH | 1 |
| Fujioka, T | 1 |
| Kodama, R | 1 |
| Kubota, T | 1 |
| Tokieda, M | 1 |
| Nasu, M | 1 |
| van der Hulst, RW | 1 |
| van der Ende, A | 1 |
| Dekker, FW | 1 |
| Ten Kate, FJ | 1 |
| Weel, JF | 1 |
| Keller, JJ | 1 |
| Kruizinga, SP | 1 |
| Dankert, J | 1 |
| Tytgat, GN | 1 |
| Katsoulis, S | 1 |
| Fölsch, UR | 1 |
| Brieva, L | 1 |
| Ara, JR | 1 |
| Bertol, V | 1 |
| Canellas, A | 1 |
| del Agua, C | 1 |
| Saita, H | 1 |
| Murakami, M | 1 |
| Takahashi, Y | 1 |
| Sou, Y | 1 |
| Kaitani, K | 1 |
| Nishio, K | 1 |
| Kita, T | 1 |
| Diebold, MD | 1 |
| Richardson, S | 1 |
| Duchateau, A | 1 |
| Bigard, MA | 1 |
| Colin, R | 1 |
| Cortot, A | 1 |
| Fauchère, JL | 1 |
| Stolte, M | 2 |
| Meining, A | 2 |
| Koop, H | 1 |
| Seifert, E | 1 |
| O'Connor, HJ | 1 |
| Schenk, BE | 2 |
| Bloemena, EC | 1 |
| Sandell, M | 1 |
| Reilly, JP | 1 |
| Pounder, RE | 1 |
| Williams, MP | 1 |
| McColl, KE | 2 |
| Murray, LS | 1 |
| Gillen, D | 2 |
| Thijs, JC | 1 |
| Luckers, AE | 1 |
| Viergever, PP | 1 |
| Weinstein, WM | 1 |
| Ohkusa, T | 1 |
| Fujiki, K | 1 |
| Takashimizu, I | 1 |
| Kumagai, J | 1 |
| Tanizawa, T | 1 |
| Eishi, Y | 1 |
| Yokoyama, T | 1 |
| Watanabe, M | 1 |
| Sanduleanu, S | 1 |
| Jonkers, D | 1 |
| de Bruïne, A | 1 |
| Hameeteman, W | 1 |
| Stockbrügger, RW | 1 |
| Hrelia, P | 1 |
| Fimognari, C | 1 |
| Maffei, F | 1 |
| Brandi, G | 1 |
| Biasco, G | 1 |
| Cantelli-Forti, G | 1 |
| Kokkola, A | 1 |
| Sipponen, P | 1 |
| Rautelin, H | 1 |
| Härkönen, M | 1 |
| Kosunen, TU | 1 |
| Haapiainen, R | 1 |
| Puolakkainen, P | 1 |
| McCloy, R | 1 |
| Solcia, E | 1 |
| Fiocca, R | 1 |
| Dalväg, A | 1 |
| Carlsson, R | 1 |
| Creutzfeldt, W | 1 |
| Lamberts, R | 1 |
| Belaïche, J | 1 |
| Bonfils, SJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparing Omeprazole With Fluoxetine for Treatment of Non Erosive Reflux Disease and Its Subgroups: a Double-blind Placebo-controlled Clinical Trial[NCT01269788] | Phase 2/Phase 3 | 144 participants (Actual) | Interventional | 2010-08-31 | Completed | ||
| The Phase 2 Study of FP-10, the Food Ingredient Derived From Milk Casein, on the Eradication Rates of Helicobacter Pylori by a Triple Therapy With Lansoprazole, Amoxicillin, and Clarithromycin[NCT00281047] | Phase 2/Phase 3 | 138 participants | Interventional | 2006-01-31 | Recruiting | ||
| Proton Pump Inhibitors in the Prevention of Iron Reaccumulation in Patient With Hereditary Hemochromatosis[NCT01524757] | 48 participants (Anticipated) | Interventional | 2012-03-31 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
13 reviews available for omeprazole and Gastritis, Atrophic
| Article | Year |
|---|---|
[Reflux esophagitis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Benzamides; Esophagitis, Peptic; Gastritis, Atrophic; | 2002 |
[Guidelines in the management of Helicobacter pylori infection in Japan].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Gas | 2003 |
Review article: the long-term use of proton-pump inhibitors.
Topics: Age Factors; Enzyme Inhibitors; Gastritis, Atrophic; Gastroesophageal Reflux; Helicobacter Infection | 2005 |
Helicobacter pylori: the place of the new macrolides in the eradication of the bacteria in peptic ulcer disease.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combinatio | 1995 |
Review article: the development of atrophic gastritis--Helicobacter pylori and the effects of acid suppressive therapy.
Topics: Animals; Anti-Ulcer Agents; Follow-Up Studies; Gastric Juice; Gastritis, Atrophic; Helicobacter Infe | 1995 |
Review article: Helicobacter pylori and gastro-oesophageal reflux disease-clinical implications and management.
Topics: Barrett Esophagus; Gastritis, Atrophic; Gastroesophageal Reflux; Helicobacter Infections; Helicobact | 1999 |
Safety profile of the proton-pump inhibitors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Diarrhea; Drug Interactions; Gastric Muc | 1999 |
Proton pump inhibitors and H. pylori infection: why the concern?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Enzyme Inhibitors; Gastritis, Atrophic; | 1999 |
Changes in gastric mucosa and luminal environment during acid-suppressive therapy: a review in depth.
Topics: Anti-Ulcer Agents; Enterochromaffin-like Cells; Fundoplication; Gastric Mucosa; Gastritis, Atrophic; | 2001 |
Problems associated with the clinical use of proton pump inhibitors.
Topics: Animals; Anti-Ulcer Agents; Carcinoid Tumor; Gastric Acid; Gastritis, Atrophic; Helicobacter Infecti | 2001 |
Is endoscopy helpful in patient monitoring?
Topics: Biopsy; Drug Monitoring; Endoscopy, Gastrointestinal; Gastritis, Atrophic; Humans; Omeprazole | 1992 |
[Effects of gastric acid secretion inhibition on intrinsic factor secretion and cobalamin absorption].
Topics: Absorption; Cimetidine; Duodenal Ulcer; Gastrectomy; Gastric Acid; Gastritis, Atrophic; Humans; Intr | 1991 |
[From acid secretion inhibition to enterochromaffin-like cell proliferation. Traps on the path].
Topics: Adenocarcinoma; Carcinoid Tumor; Enterochromaffin Cells; Gastric Mucosa; Gastrins; Gastritis, Atroph | 1991 |
10 trials available for omeprazole and Gastritis, Atrophic
| Article | Year |
|---|---|
Relationship of Helicobacter pylori eradication with gastric cancer and gastric mucosal histological changes: a 10-year follow-up study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Female; Follow | 2014 |
Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure.
Topics: Adenocarcinoma; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; | 2002 |
The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Met | 2003 |
Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Disease Progression; Double- | 2004 |
Effect of hypochlorhydria due to omeprazole treatment or atrophic gastritis on protein-bound vitamin B12 absorption.
Topics: Absorption; Achlorhydria; Administration, Oral; Aged; Aged, 80 and over; Female; Gastric Acid; Gastr | 1994 |
Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Cohort Studies; Esophagitis, Peptic; | 1996 |
[Reflux esophagitis; is the preventive eradication of Helicobacter pylori needed in patients on omeprazole?].
Topics: Enzyme Inhibitors; Esophagitis, Peptic; Female; Gastritis, Atrophic; Gastroesophageal Reflux; Helico | 1998 |
Factors influencing Helicobacter pylori eradication with 2 week combination therapy of lansoprazole and amoxycillin: intragastric distribution of colonization and gastric mucosal atrophy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Drug Administration Sch | 1998 |
Factors influencing corpus argyrophil cell density and hyperplasia in reflux esophagitis patients treated with antisecretory drugs and controls.
Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Cell Count; Cross-Sectional Studies; Enterochroma | 1998 |
Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Case-Control Studies; Clarithrom | 2000 |
30 other studies available for omeprazole and Gastritis, Atrophic
| Article | Year |
|---|---|
Octreotide-based therapies effectively protect mice from acute and chronic gastritis.
Topics: Animals; Clarithromycin; Ethanol; Gastric Mucosa; Gastritis; Gastritis, Atrophic; Helicobacter Infec | 2022 |
Weikangling capsules combined with omeprazole ameliorates ethanol-induced chronic gastritis by regulating gut microbiota and EGF-EGFR-ERK pathway.
Topics: Animals; Capsules; Epidermal Growth Factor; ErbB Receptors; Ethanol; Gastritis, Atrophic; Gastrointe | 2023 |
PPIs and gastric cancer: any causal relationship?
Topics: Causality; Gastritis, Atrophic; Humans; Omeprazole; Proton Pump Inhibitors; Stomach Neoplasms | 2023 |
[Helicobacter pylori infection in the HIV + population: a comorbidity to think about].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Ulcer Agents; Clarithromycin; Comor | 2020 |
Gastric mucosal changes, and sex differences therein, after Helicobacter pylori eradication: A long-term prospective follow-up study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Atrophy; Clarithromycin; Female; Follow-Up Studies; | 2021 |
Improvement of long-standing iron-deficiency anemia in adults after eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial | 2002 |
Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Cyclooxygenase 2; Drug Therapy, Combination; Female; | 2003 |
Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anemia, Iron-Deficiency; Antibodies, Bacterial; Autoantibodies | 2005 |
Omeprazole treatment ameliorates oxyntic atrophy induced by DMP-777.
Topics: Analysis of Variance; Animals; Azetidines; Disease Models, Animal; Drug Interactions; Gastric Acid; | 2006 |
Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety.
Topics: Antacids; Biopsy; Endoscopy, Digestive System; Female; Gastric Mucosa; Gastritis; Gastritis, Atrophi | 1995 |
Long-term omeprazole therapy in peptic ulcer disease.
Topics: Animals; Gastritis, Atrophic; Humans; Omeprazole; Peptic Ulcer; Rats | 1993 |
Apparent reversal of early gastric mucosal atrophy after triple therapy for Helicobacter pylori.
Topics: Anti-Bacterial Agents; Antibodies, Bacterial; Bismuth; Drug Therapy, Combination; Gastric Mucosa; Ga | 1993 |
Folate synthesized by bacteria in the human upper small intestine is assimilated by the host.
Topics: 4-Aminobenzoic Acid; Adult; Aged; Analysis of Variance; Anti-Ulcer Agents; Bacteria; Female; Folic A | 1996 |
Atrophic gastritis and Helicobacter pylori in reflux esophagitis.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Esophagitis, Peptic; Gastritis, Atrophic; Helicobacter Inf | 1996 |
Helicobacter pylori infection accelerates human gastric mucosal cell proliferation.
Topics: Amoxicillin; Anti-Ulcer Agents; Biopsy; Case-Control Studies; Cell Division; Drug Therapy, Combinati | 1997 |
Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study.
Topics: Amoxicillin; Antigens, Bacterial; Bacterial Proteins; Drug Therapy, Combination; Female; Follow-Up S | 1997 |
Lansoprazole, H. pylori, and atrophic gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Enzyme Inhibitors; Gastritis, Atrophic; Helicobacter Infect | 1997 |
[Is long-term acid suppression dangerous in existing Helicobacter pylori infection?].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Esophagitis, Peptic; Female; Fundopli | 1997 |
[Polyneuropathy caused by vitamin B12 deficiency secondary to chronic atrophic gastritis and giardiasis].
Topics: Amoxicillin; Anemia, Pernicious; Anti-Bacterial Agents; Antiprotozoal Agents; Bismuth; Duodenitis; E | 1998 |
Eradication of Helicobacter pylori heals atrophic corpus gastritis caused by long-term treatment with omeprazole.
Topics: Adult; Anti-Ulcer Agents; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; | 1999 |
Atrophic gastritis during long-term omeprazole therapy affects serum vitamin B12 levels.
Topics: Absorption; Anti-Ulcer Agents; Cohort Studies; Drug Administration Schedule; Female; Gastritis, Atro | 1999 |
Omeprazole and accelerated onset of atrophic gastritis.
Topics: Anti-Ulcer Agents; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Omepra | 2000 |
Omeprazole and accelerated onset of atrophic gastritis.
Topics: Anti-Ulcer Agents; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Omepra | 2000 |
Omeprazole and accelerated onset of atrophic gastritis.
Topics: Anti-Ulcer Agents; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Omepra | 2000 |
Lack of effect of acid suppression therapy on gastric atrophy.
Topics: Anti-Ulcer Agents; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Omepra | 2000 |
Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Biop | 2001 |
Mutagenic and clastogenic activity of gastric juice in human gastric diseases.
Topics: Adult; Aged; Anti-Ulcer Agents; Chronic Disease; Female; Gastric Juice; Gastritis, Atrophic; Humans; | 2002 |
The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Drug Combinations | 2002 |
Gastric endocrine cells and gastritis in patients receiving long-term omeprazole treatment.
Topics: Adult; Biopsy; Esophagitis, Peptic; Gastric Mucosa; Gastritis, Atrophic; Humans; Hyperplasia; Incide | 1992 |
Inter-relationship between serum gastrin levels, gastric mucosal histology and gastric endocrine cell growth.
Topics: Biopsy; Esophagitis, Peptic; Gastric Mucosa; Gastrins; Gastritis, Atrophic; Humans; Hyperplasia; Lon | 1992 |